Quote this publication Share Print

SIFROL

-
Opinions on drugs - Posted on Jun 24 2009

Reason for request

: Inclusion on the list of medicines reimbursed by National Insurance and approved for use in hospital in the indication: symptomatic treatment of moderate to severe idiopathic Restless Legs

-


Actual benefit

Insuffisant

The actual benefit of SIFROL is insufficient for all other forms.

Important

The actual benefit of SIFROL will be substantial in very severe forms of idiopathic RLS.


Improvement in actual benefit

IV (mineur)

SIFROL share the same the level of ASMR IV with ADARTREL (ropinirole) in the management of patients with very severe idiopathic restless legs syndrome.


Contact Us

Évaluation des médicaments